Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07213999 · ClinicalTrials.gov registry record · NA
Novel DBS Device in Parkinson's Disease
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT07213999 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 1 participants.
The verdict
NCT07213999, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this research is to test a new recorder that can measure brain activity when stimulation is turned on during deep brain stimulation (DBS) surgery. To continue to improve DBS therapy, the investigators need to better understand the changes in the brain of people with Parkinson's disease (PD). They also need to know how this is affected by DBS. Current recorders measure activity immediately after, but not during, stimulation. Standard-of-care DBS already includes the electrical recording of brain activity during movement of arms and legs. These recordings occur during the microelectrode recording part of the surgery and are used by the medical team to determine where to place the DBS electrode.
Interventions
- DEVICE Novel neural recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2022-07-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07213999
The ClinicalTrials.gov registry entry for NCT07213999 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Novel neural recorder is the first listed.
NCT07213999 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07213999 about?
NCT07213999 is a clinical study titled "Novel DBS Device in Parkinson's Disease". The purpose of this research is to test a new recorder that can measure brain activity when stimulation is turned on during deep brain stimulation (DBS) surgery. To continue to improve DBS therapy, the investigators need to better understand the changes in the brain of people with Parkinson's diseas...
What is the current status of trial NCT07213999?
This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2022-07-01. Estimated completion is 2022-07-02.
What interventions are being tested in trial NCT07213999?
The interventions under investigation include: Novel neural recorder (DEVICE).
Who is sponsoring clinical trial NCT07213999?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.